Children with Sickle Cell Anemia Experience Severe Oxygen Desaturation During Night and After Six-Minute Walk Distance Test

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4766-4766
Author(s):  
Isabelle Halphen ◽  
Caroline Elie ◽  
Valentine Brousse ◽  
Muriel Le Bourgeois ◽  
Damien Bonnet ◽  
...  

Abstract Abstract 4766 Background: Respiratory complications are the first causes of death among adult patients with sickle cell anemia (SCA). Finding risk factors for children is important. We study clinical, biological, respiratory and heart parameters, as well as exercise and sleep oxygen saturation in SCA children. Patients and Methods: We conducted a prospective study in homozygous SS or S/beta 0 thalassemic children. A chronic transfusion program was an exclusion criterion. We recorded the number of vaso-occlusive crises (VOC) the year before and after inclusion, past history of acute chest syndrome (ACS), hydroxyurea treatment, tonsils size, baseline heart rate and blood pressure, baseline hemoglobin (Hb), reticulocytes, fetal Hb levels, leukocytes and platelets counts, total bilirubin, aspartate aminotransferase (AST), lactate deshydrogenase (LDH). All patients underwent respiratory function testing (RFT), echocardiography assessing tricuspid regurgitation velocity jet (TRV). We measured daytime oxygen saturation using a Radical Masimo set ® pulse oximeter. All patients underwent a non-encouraged six-minute walk test (6MWT). Nocturnal pulse oximetry was recorded using a Nonin ® device during 3 consecutive nights for 30 patients. We considered the average night-time oxygen saturation and the percentage of sleep time with oxygen saturation less than 90%. Statistical analysis was conducted using the Fisher exact test for categorical variables and the Wilcoxon test for continuous variables. Results: Forty-two unselected SCA children were enrolled. Three patients were secondarily excluded because the echocardiography revealed asymptomatic cardiac anomalies (two pulmonary valve stenosis and one persistent arterial canal). In the remaining 39 patients, 38 were SS and one was S/beta 0 thalassemic. Median age was 10.8 years (range 5.7–17); 25 patients were females (64%). The median number of VOC was 0 the year before inclusion (range 0–6), and 0 the year after (range 0–7). Fifteen patients (38%) had displayed at least one ACS. Nine patients (23%) were receiving hydroxyurea treatment. Sixteen patients (43%) had tonsillitis enlargement. Median basal heart rate was 97 bpm (range 75–122). Mean systolic blood pressure was 107 ± 11.3 mm Hg and mean diastolic blood pressure was 64 ± 6.6 mm Hg. Mean Hb was 7.9 ± 1.2 g/dL, mean reticulocyte count was 236 ± 82 Giga/L, median HbF was 9.2 % (range 0.8–28), mean leukocyte count was 11.1 ± 3.2 Giga/L, mean platelet count was 407 ± 132 Giga/L. Median total bilirubin, AST, and LDH were, respectively, 41.5 mg/dL (range 13–163), 62 UI/l (range 35–132), and 1421 UI/l (range 618–1893) (normal range for LDH in our lab 125–243). Fifteen patients (38.5%) had abnormal RFT: 4 had obstructive pattern, 3 had restrictive pattern, and 3 had both. Left ventricular diastolic function was normal for all patients. Six patients had a TRV above 2.6 m/s. Median daytime oxygen saturation was 97 % (range 89–100). One patient had a daytime saturation below 92%. Median nocturnal oxygen saturation was 94.7 % (range 87.7–99.5). Ten patients (33%) displayed average night-time saturation below 92%. Eleven patients (37%) spent more than 10% of their sleep time with oxygen saturation below 90%. Mean six-minute walk distance (6MWD) was 547 ± 99 m. After the 6MWT, 14 patients (35%) had an oxygen saturation below 92%. Median difference in oxygen saturation before and after the test was 2% (range −57, +2). Nocturnal hypoxemia was not associated with age, gender, tonsils size, hydroxyurea treatment, past history of ACS, RFT pattern, number of VOC, leukocytes, platelets, LDH, bilirubin nor AST. It was associated with Hb level (7.2±1.2 g/dL if nocturnal hypoxemia vs 8.4±1.1, p=0.02), daytime oxygen saturation (94% [range 92–99] if nocturnal hypoxemia vs 98% [range 89–100], p=0.03), and oxygen saturation after 6MWT (91% [range 40–99] if nocturnal hypoxemia vs 96% [range 79–100], p=0.03). Children with a TRV above 2.6m/s had a significantly lower Hb level (7.4 g/dL [6.4–8.1] vs 8.5 [6.5–10.6]). Conclusions: Our study emphasizes the frequency of night-time oxygen desaturation in SCA children. It shows that a simple effort can induce a significant decrease in oxygen saturation. The consequences of hypoxemia are difficult to assess given the small sample size. One can hypothesize that hypoxemia and hypoxia/reoxygenation cycles both contribute to the pathophysiology of the disease through inflammation and vascular injury. Disclosures: No relevant conflicts of interest to declare.

Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 538
Author(s):  
Yuichiro Ikebuchi ◽  
Kazuya Matsumoto ◽  
Naoki Ueda ◽  
Taro Yamashita ◽  
Hiroki Kurumi ◽  
...  

This randomized trial aimed to compare the safety and efficacy of the GAGLESS mouthpiece for esophagogastroduodenoscopy (EGD) with that of the conventional mouthpiece. In all, 90 participants were divided into the GAGLESS mouthpiece and conventional mouthpiece groups. The primary endpoint was the severity of pain using the visual analog scale (VAS), and secondary endpoints were examination time, past history of endoscopy, success of the procedure, systolic (SBP) and diastolic (DBP) blood pressure, oxygen saturation, pulse rate before and after EGD, and adverse events. Endoscopy was completed in all cases, and no complications were observed. VAS, when passing the scope through the pharynx, was 2.5 ± 2.4 and 2.0 ± 1.9 cm (p = 0.24) in the conventional and GAGLESS groups, respectively, and that, throughout the examination, was 2.5 ± 2.4 and 1.7 ± 1.5 cm (p = 0.06), respectively. The difference in blood pressure between the GAGLESS and conventional groups was not significant for SBP (p = 0.08) and significant for DBP (p = 0.03). The post-EGD difference in DBP was significantly lower in the GAGLESS group than in the conventional group. The results indicate that GAGLESS mouthpieces had a lower VAS during endoscopy than the conventional mouthpieces, and the changes in blood pressure were smaller with the GAGLESS mouthpiece.


2021 ◽  
Author(s):  
Shigui Yang ◽  
Chenyang Huang ◽  
Qingmiao Sun ◽  
Daixi JIang ◽  
Xiaobao Zhang ◽  
...  

BACKGROUND Background: Wearing a mask is one of the most effective measures to prevent COVID-19 virus infection and it is not yet clear what potential factors may be associated with facial skin problems while wearing masks. OBJECTIVE Objective: seek most suitable mask-wearing habits for public to avoid facial skin problem. METHODS Method: A cross-sectional survey was conducted through online and offline questionnaires on patterns of mask wearing and facial skin problems during COVID-19 from May 30-July 1, 2020. Multivariable regression was used to explore the potential factors associated with skin problems. We also recruited 19 subjects and compared the differences in their facial microbiomes before and after wearing masks. RESULTS Results: A total of 4385 valid questionnaires were finally analyzed and 1323 (33.1%) participants reported having facial skin problems while wearing masks. The risk factors associated with skin problems were having a history of facial skin problems (OR: 3.25, 95% CI: 2.80-3.76), facial skin allergies (OR: 1.37, 95% CI: 1.20-1.56), face washing frequency (≥3 times per day) (OR: 1.61, 95% CI: 1.07-2.43), daily sleep time <6 hours (OR: 2.38, 95% CI: 1.81-3.13), and average time spent wearing masks uninterruptedly ≥6 hours (OR: 1.67, 95% CI: 1.24-2.25). The analysis of the facial microbiome revealed that the abundance of Prevotella and Hemophilus decreased, and the functional pathway associated with cytochrome c was more predominant with the prolongation of wearing time. CONCLUSIONS Conclusion: The habit of wearing a mask and life behavior affect the occurrence of skin damage. Suitable mask types and mask-wearing habits should be recommended to avoid facial skin problems. CLINICALTRIAL NA


Author(s):  
Matthew J Lennon ◽  
Ben Chun Pan Lam ◽  
John Crawford ◽  
Henry Brodaty ◽  
Nicole A Kochan ◽  
...  

Abstract Background While midlife hypertension is deleterious, late-life hypertension has been associated with better cognitive outcomes in several studies. Many questions remain, including the relative benefit or harm of a blood pressure (BP) target and antihypertensive therapy of &lt;120 in very old individuals. Methods The Sydney Memory and Aging Study (n = 1015) comprises a cohort of 70- to 90-year-olds, who were followed biennially for 8 years. Global cognition was assessed with a battery of 10 neuropsychological tests. Blood pressure was measured at Waves 1 and 2 and classified into 3 systolic groupings: group 1 (≤120 mmHg), group 2 (121–140 mmHg), and group 3 (&gt;140 mmHg). Multiple regression, linear mixed modeling, and Cox regression examined the effect of BP and antihypertensives. Results There were no overall significant differences in global cognition or dementia between the disparate BP groups. However, in those not taking antihypertensives, the systolic BP (SBP) &gt; 140 mmHg group had a significantly worse global cognitive trajectory compared to SBP ≤ 120 mmHg (b = −0.067, 95% CI [−0.129, −0.006], p = .030). Within the SBP ≤ 120 mmHg group those taking antihypertensives had significantly worse global cognition trajectories compared to those not taking antihypertensives even when controlling for past history of hypertension (b = −0.077, 95% CI [−0.147, −0.007], p = .030). Conclusions Untreated hypertension in old age is related to worse global cognitive decline. However, ongoing treatment at new recommendations of lower SBP targets may be related to poorer cognitive decline and should be considered carefully in older populations.


1985 ◽  
Vol 151 (1) ◽  
pp. 28-32 ◽  
Author(s):  
Charles C. Tsai ◽  
H.Oliver Williamson ◽  
Bonnie H. Kirkland ◽  
Judy O. Braun ◽  
Chan F. Lam

2021 ◽  
Vol 17 (1) ◽  
pp. 12-20
Author(s):  
A. M. Kochergina ◽  
O. L. Barbarash

Arterial hypertension (AH) is a common modifiable cardiovascular risk factor. Despite the wide choice of antihypertensive drugs, according to epidemiological studies, just over 20% of patients demonstrate effective control of hypertension. Failure to achieve the target values of blood pressure (BP) determines a high probability of developing cardiovascular events, which is also true for patients undergoing percutaneous coronary interventions (PCI). However, there is evidence that individuals who have undergone PCI show a higher percentage of achieving the target blood pressure levels. Aim of the study was to evaluate the dynamics of blood pressure indicators in patients with stable coronary artery disease (CAD) and diabetes mellitus, depending on the fact of performing PCI.Material and methods. The study was conducted at federal state budgetary scientific institution research institute of complex issues of cardiovascular diseases as a prospective, open, not comparative. The study included 75 patients with stable CAD and type 2 diabetes who regularly received therapy for at least 1 month prior to the start of participation in this study. The majority of patients 45 (60%) are represented by males. The median age was 52.64±6.96 years. 44 patients (58.81%) had a history of myocardial infarction, and 46 patients (61.33%) had previously undergone myocardial revascularization, history of stroke had 5 patients (6.66%). All patients according to the daily blood pressure monitoring at the 1st visit had average daily blood pressure values above 130/80 mmHg. Participants were divided into 2 groups: 43 patients had indications for routine PCI at the time of inclusion in the study, 32 patients had no indications for revascularization. The groups did not have significant differences in clinical and anamnestic characteristics, and regular significant differences were noted in relation to previously undergone revascularization (46.51 and 81.25%, respectively, p=0.0022) and the SYNTAX Score (14.39±9.20 and 6.13±8.28, respectively, p=0.0001). During 4 visits (1 visit, 1 month, 3 months, 6 months), ambulatory blood pressure monitoring (ABPM) was performed using the BiPiLAB system.Results. Initially according ABPM parameters group without the alleged PCI had greater variability in systolic blood pressure (SBP) in the daytime, higher values of mean diastolic blood pressure (DBP) at night, more time index of hypertension DBP at night. After 1 month of follow — up (for the group with PCI 1 month after the procedure), there were significant differences in the average daily SBP and DBP, the index of the time of hypertension DBP in the daytime, and the average daily SBP. Patients who underwent revascularization had lower ABPM values. The previously described differences in the night time DBP and the index of hypertension time at night were preserved. After 3 months of follow-up, significant differences were observed only in the indicators of night time SAD and DBP. At the end of the study (6 months of follow-up), the groups had differences only in the indicators of mean diastolic pressure at night.Conclusion. Patients who underwent PCI for 1 month after the procedure have a significant tendency to normalize (compared to the group without revascularization) blood pressure indicators. However, over time, the effect «escapes». Most likely, the short-term improvement in blood pressure is due to a temporary improvement in treatment adherence after an invasive procedure.


2015 ◽  
Vol 40 (2) ◽  
pp. 70-73 ◽  
Author(s):  
AKM Mosharraf Hossain ◽  
R Chakrabortty

Introduction: The six minute walk test (6MWT) is increasingly accepted worldwide to assess functional exercise capacity of cardiac and pulmonary diseases for its simplicity.Aims and objectives: The aim of the present study was to provide reference values for 6 Minute Walk Distance (6MWD) and other primary variables such as oxygen saturation (SaO2), pulse rate (PR) and breathlessness perception done in 6MWT.Methods: We studied a sample of 190 healthy subjects (53 females) of age between 25-55 years (37.9±8.5 years). Baseline lung functions including forced expiratory volume in 1st second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio were measured by a flow sensing spirometer. All subjects performed 6MWT according to standard protocol provided by the American Thoracic Society (ATS) guidelines. The fatigue and dyspnoea was measured before and after 6MWT by modified Borg scale. The SaO2 and PR were measured also by a light weight pulse oxymeter. Results: The mean 6MWD was 466.7±69.4 meter, ranging from 213 to 659 meter and the mean Distance Work (DW) was 28732±7024 kg-m. Dyspnoea status and oxygen saturation remained unaltered throughout the walk. Mean resting and walking SaO2 values were, respectively, 97.1±1.3% and 96.8±1.5%. The mean change in SaO2 was 3±1.5%. PR was significantly affected by the walk. Mean resting and maximum PR after walking were respectively, 80±7 and 103±12 bpm (p<.01). Gender significantly affected the 6MWD (p<.01). In all subjects, the 6MWD was inversely and directly related, respectively, to age (r=-.15; P<.05) and height (r=.41; P<.01).Conclusion: This study showed reference values for the 6MWT variables of subjects in Bangladeshi population.Bangladesh Med Res Counc Bull 2014; 40 (2): 70-73


2015 ◽  
Vol 114 (8) ◽  
pp. 1263-1277 ◽  
Author(s):  
Verena Brüll ◽  
Constanze Burak ◽  
Birgit Stoffel-Wagner ◽  
Siegfried Wolffram ◽  
Georg Nickenig ◽  
...  

AbstractThe polyphenol quercetin may prevent CVD due to its antihypertensive and vasorelaxant properties. We investigated the effects of quercetin after regular intake on blood pressure (BP) in overweight-to-obese patients with pre-hypertension and stage I hypertension. In addition, the potential mechanisms responsible for the hypothesised effect of quercetin on BP were explored. Subjects (n 70) were randomised to receive 162 mg/d quercetin from onion skin extract powder or placebo in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 6-week washout period. Before and after the intervention, ambulatory blood pressure (ABP) and office BP were measured; urine and blood samples were collected; and endothelial function was measured by EndoPAT technology. In the total group, quercetin did not significantly affect 24 h ABP parameters and office BP. In the subgroup of hypertensives, quercetin decreased 24 h systolic BP by −3·6 mmHg (P=0·022) when compared with placebo (mean treatment difference, −3·9 mmHg; P=0·049). In addition, quercetin significantly decreased day-time and night-time systolic BP in hypertensives, but without a significant effect in inter-group comparison. In the total group and also in the subgroup of hypertensives, vasoactive biomarkers including endothelin-1, soluble endothelial-derived adhesion molecules, asymmetric dimethylarginine, angiotensin-converting enzyme activity, endothelial function, parameters of oxidation, inflammation, lipid and glucose metabolism were not affected by quercetin. In conclusion, supplementation with 162 mg/d quercetin from onion skin extract lowers ABP in patients with hypertension, suggesting a cardioprotective effect of quercetin. The mechanisms responsible for the BP-lowering effect remain unclear.


2020 ◽  
Vol 15 ◽  
Author(s):  
Francesco P Cappuccio

The accurate measurement, prediction and treatment of high blood pressure (BP) are essential to the management of hypertension and the prevention of its associated cardiovascular (CV) risks. However, even if BP is optimally controlled during the day, nocturnal high blood pressure may still increase the risk of CV events. The pattern of circadian rhythm of BP can be evaluated by ambulatory BP monitoring (ABPM). Night-time ABPM is more closely associated with fatal and nonfatal CV events than daytime ambulatory BP. However, the use of ABPM is limited by low availability and the fact that it can cause sleep disturbance, therefore may not provide realistic nocturnal measurements. Home blood pressure monitoring (HBPM) offers an inexpensive alternative to ABPM, is preferred by patients and provides a more realistic assessment of BP during an individual’s daily life. However, until recently, HBPM did not offer the possibility to measure nocturnal (sleep time) BP. The development and validation of new BP devices, such as the NightView (OMRON Healthcare, HEM9601T-E3) HBPM device, could overcome these limitations, offering the possibility of daytime and night-time BP measurements with minimal sleep disturbance.


2018 ◽  
Vol 14 (1) ◽  
Author(s):  
M González

Objetive: A descriptive, cross-sectional studywas performed to determine the cardiorespiratoryeffects in child’s first dental visit to thePediatric Dental Clinic at Alas Peruanas University,without the presence of any pre-existingcondition, such as pain, previous traumatic dentalvisits, use of medications and systemic diseases. Material and méthodos: To accomplish this, heart rate, oxygen saturation, blood pressure,body temperature and respiratory rate were recordedon 70 children before (waiting room) andafter first dental visit (operating room) using afinger pulse oximeter, digital sphygmomanometer,thermometer and a wristwatch.  Results:showed basal and postoperative body temperatureregistered 36° C and 36.1° C, respectively.Basal systolic blood pressure registered 96 mmHg and postoperative 93 mm Hg, and basaldiastolic blood pressure registered 63 mm Hgand postoperative 63 mm Hg. Basal oxygen saturationregistered 96% and postoperative 93%.Basal heart rate registered 88 bpm and postoperative85 bpm. Basal respiratory rate registered20 bpm and postoperative 20 bpm. The authorconcluded that significant cardiorespiratorychanges exist during first dental visit, existingsignificant differences in oxygen saturation andrespiratory rate recorded before and after dentalcare.


Sign in / Sign up

Export Citation Format

Share Document